Metabolic diseases are serious threats to public health and related to gut microbiota.
Probiotics, prebiotics, synbiotics, and postbiotics (PPSP) are powerful regulators of gut …

Objective To systematically review the effect of oral intake of bacterial probiotics on 15
variables related to obesity, diabetes and non-alcoholic fatty liver disease. Design …

Aims/hypothesis The aim was to conduct a systematic review and meta-analysis of
randomised controlled clinical trials assessing the effect of probiotic, prebiotic or synbiotic …

The growing disease burden of diabetes mellitus is an important public health concern,
affecting over 400 million people globally. This epidemic, if not controlled in time, leads to …

Non-alcoholic fatty liver disease (NAFLD) is a metabolic stress liver injury that is closely
related to obesity, insulin resistance, type 2 diabetes, atherosclerosis, and metabolic …

This meta-analysis examined the effect of probiotics on outcomes associated with
cardiovascular disease risk factors (high blood pressure, overweight BMI, high cholesterol …

Diabetes Mellitus (DM) is an inflammatory clinical entity with different mechanisms involved
in its physiopathology. Among these, the dysfunction of the gut microbiota stands out …

Aim/hypothesis The globally escalating diabetes epidemic is responsible for significant
morbidity and mortality. Microbiome-modulating nutraceuticals have been investigated for …

Obesity is currently considered a global epidemic and it leads to several alterations on the
human body and its metabolism. There are evidences showing that the intestinal microbiota …

Background: Alow carbohydrate diet (LCD) is more beneficial for the glycometabolism in
type 2 diabetes (T2DM) and may be effective in reducing depression. Almond, which is a …